
Peter James Goadsby MD
Professor, Department of Neurology, University of California, San Francisco.
Join to view full profile
100 Medical Plaza DriveSuite #425Los Angeles, CA 90095
Phone+1 310-301-6800
Dr. Goadsby is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of New South Wales Faculty of MedicineClass of 1985
Certifications & Licensure
CA State Medical License 2007 - 2024
Clinical Trials
Publications & Presentations
PubMed
- 16 citationsUbrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial.Peter J Goadsby, Jessica Ailani, David W Dodick, Amaal J Starling, Chengcheng Liu
Nature Medicine. 2025-07-01 - 10 citationsEfficacy and Safety of Eptinezumab in Episodic Cluster Headache: A Randomized Clinical Trial.Rigmor H Jensen, Cristina Tassorelli, Stewart J Tepper, Andrew Charles, Peter J Goadsby
JAMA Neurology. 2025-07-01 - 6 citationsConcomitant anti-CGRP and immunomodulatory treatments in patients with migraine: towards integrated management strategies.María Clara García-Castillo, Álvaro Sierra-Mencía, Edoardo Caronna, Daniel Toledo-Alfocea, Alex Jaimes
Journal of Neurology. 2025-06-03
Lectures
- Headache Cooperative of the Pacific 5th Annual Winter ConferenceHeadache Cooperative of the Pacific, Ojai, California - 1/27/2012
Other
- Pathophysiology of the trigeminal autonomic cephalalgiasGoadsby PJ, Cohen AS, May A
http://www.uptodate.com/contents/pathophysiology-of-the-trigeminal-autonomic-cephalalgias
UpToDate, Wolters Kluwer Health - 2013-01-17
Press Mentions
Ubrogepant During Prodromal Phase of Migraine Eases SymptomsMay 14th, 2025
Drug Said to Be Effective Against Early Migraine SymptomsMay 14th, 2025
Ubrogepant During Prodromal Phase of Migraine Eases SymptomsMay 14th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









